Projects per year
Personal profile
Personal profile
Dr. Wafaa El-Sadr is the founder and director of ICAP and an international expert in infectious diseases and public health with extensive experience in epidemiology and research on the prevention and management of HIV, tuberculosis, malaria, and emerging infections, among others. She is also the director of Columbia World Projects and director of the Mailman School's Global Health Initiative (GHI), which mobilizes the university community to address critical challenges in global health. For over four decades, she has advocated for families and communities most impacted by health challenges and championed a collaborative, multidisciplinary approach to confronting the global epidemic. Based at Columbia University, she leads ICAP's portfolio of projects in more than 30 countries and manages a global team of over 2,000 staff. Under her leadership, ICAP has become a global leader in addressing global health challenges and health systems strengthening. Dr. El-Sadr began her career as the HIV epidemic took hold in the United States. As chief of the Division of Infectious Diseases at Harlem Hospital, she developed successful methods for responding to HIV/AIDS through groundbreaking research and innovative models of care in her own community. Dr. El-Sadr became a leader in the global fight against HIV by arming health care systems around the world with effective strategies for confronting the impact of various health challenges and leveraging investment to strengthen health systems. She is the principal investigator for numerous ICAP-led research initiatives and a principal investigator of the NIH-funded HIV Prevention Trials Network (HPTN). Dr. El-Sadr received her medical degree at Cairo University, a master's in public health (epidemiology) from Columbia University Mailman School of Public Health, and a master's in public administration from Harvard University Kennedy School of Government. She joined the faculty of Columbia's College of Physicians and Surgeons in 1988 and became a professor of epidemiology and medicine at the Mailman School of Public Health. In 2013, she was appointed University Professor, Columbia's highest academic title. She also holds the Dr. Mathilde Krim-amfAR Chair in Global. She is a MacArthur fellow, as well as a member of the National Academy of Medicine, the Council for Foreign Relations, and the African Academy of Sciences.
Research interests
- Global Health
- HIV/AIDS
- Infectious Diseases
Urban Health Activities
Community Outcomes of Assisted Outpatient Treatment
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MPA, Harvard University
… → 1996
MPH, Mailman School of Public Health
… → 1991
MD, Cairo University
… → 1974
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 54 Finished
-
Novel predictors of survival among breast cancer patients with/without HIV in South Africa
Cubasch, H. (CoPI), El-Sadr, W. M. (CoPI), Jacobson, J. S. (CoPI), Joffe, M. (PI), Neugut, A. I. (CoPI) & Ruff, P. (CoPI)
6/1/21 → 5/31/22
Project: Research project
-
ICAP Clinical Trials Unit
El-Sadr, W. M. (PI) & Justman, J. E. (CoPI)
National Institute of Allergy and Infectious Diseases
12/1/20 → 11/30/21
Project: Research project
-
IPrEP: A Combination HIV Prevention Strategy for Young Women at Risk for HIV
El-Sadr, W. M. (PI) & Agot, K. (CoPI)
National Institute of Mental Health
9/22/16 → 6/30/21
Project: Research project
-
Next Generation
El-Sadr, W. M. (PI)
National Institute on Minority Health and Health Disparities
12/1/13 → 11/30/19
Project: Research project
-
LINK4HEALTH: A Combination Strategy for Linkage and Retention, Swaziland
El-Sadr, W. M. (PI)
National Institute of Allergy and Infectious Diseases
6/15/12 → 5/31/17
Project: Research project
-
Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART study
HPTN 071 (PopART) Phylogenetics protocol team & PANGEA consortium, Jan 2024, In: The Lancet Microbe. 5, 1, p. e62-e71Research output: Contribution to journal › Article › peer-review
Open Access -
Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial
for the IMPAACT P1078 T. B. APPRISE study team, Dec 2023, In: BMC Pregnancy and Childbirth. 23, 1, 34.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Trends in HIV prevalence, incidence, and progress towards the UNAIDS 95-95-95 targets in Malawi among individuals aged 15–64 years: population-based HIV impact assessments, 2015−16 and 2020−21
MPHIA Study Team, Sept 2023, In: The Lancet HIV. 10, 9, p. e597-e605Research output: Contribution to journal › Article › peer-review
Open Access13 Citations (Scopus) -
Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling study
HPTN 071 (PopART) Study Team, Nov 2022, In: The Lancet HIV. 9, 11, p. e771-e780Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Rates of viral suppression in a cohort of people with stable HIV from two community models of ART delivery versus facility-based HIV care in Lusaka, Zambia: a cluster-randomised, non-inferiority trial nested in the HPTN 071 (PopART) trial
HPTN 071 (PopART) Study Team, Jan 2022, In: The Lancet HIV. 9, 1, p. e13-e23Research output: Contribution to journal › Article › peer-review
Open Access12 Citations (Scopus)